KALA BIO, INC. Shares Outstanding (Cover Page)
KALA BIO, INC. (KALA) had Shares Outstanding (Cover Page) of 19.34 million shares as of 2026-08-14, per its 10-Q filed 2026-08-19.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-19
- 2026-08-14: Entity Common Stock, Shares Outstanding 19.34M shares.
- 2026-05-14: Entity Common Stock, Shares Outstanding 18.59M shares.
- 2026-04-10: Entity Common Stock, Shares Outstanding 929.49M shares.
- 2025-11-18: Entity Common Stock, Shares Outstanding 8.21M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-14 | 19.34M shares 10-Q · filed 2026-08-19 |
| 2026-05-14 | 18.59M shares 10-Q · filed 2026-05-15 |
| 2026-04-10 | 929.49M shares 10-K · filed 2026-04-15 |
| 2025-11-18 | 8.21M shares 10-Q · filed 2025-11-19 |
| 2025-08-07 | 7.02M shares 10-Q · filed 2025-08-08 |
| 2025-05-13 | 6.45M shares 10-Q · filed 2025-05-14 |
| 2025-03-28 | 6.45M shares 10-K · filed 2025-03-31 |
| 2024-11-11 | 4.61M shares 10-Q · filed 2024-11-12 |
| 2024-08-05 | 4.61M shares 10-Q · filed 2024-08-06 |
| 2024-05-13 | 2.82M shares 10-Q · filed 2024-05-14 |
| 2024-03-28 | 2.82M shares 10-K · filed 2024-03-29 |
| 2023-11-10 | 2.69M shares 10-Q · filed 2023-11-13 |
| 2023-08-03 | 2.54M shares 10-Q · filed 2023-08-04 |
| 2023-05-08 | 2.35M shares 10-Q · filed 2023-05-09 |
| 2023-03-02 | 2.03M shares 10-K · filed 2023-03-03 |
| 2022-11-07 | 1.52M shares 10-Q · filed 2022-11-08 |
| 2022-08-10 | 73.21M shares 10-Q · filed 2022-08-11 |
| 2022-05-13 | 72.59M shares 10-Q · filed 2022-05-16 |
| 2022-03-28 | 72.59M shares 10-K · filed 2022-03-29 |
| 2021-11-12 | 65.50M shares 10-Q · filed 2021-11-15 |
| 2021-08-04 | 64.97M shares 10-Q · filed 2021-08-05 |
| 2021-05-04 | 64.64M shares 10-Q · filed 2021-05-05 |
| 2021-02-24 | 61.55M shares 10-K · filed 2021-02-25 |
| 2020-11-04 | 56.08M shares 10-Q · filed 2020-11-05 |
| 2020-08-03 | 56.06M shares 10-Q · filed 2020-08-06 |
| 2020-05-05 | 55.72M shares 10-Q · filed 2020-05-07 |
| 2020-02-10 | 36.80M shares 10-K · filed 2020-02-12 |
| 2019-11-04 | 34.54M shares 10-Q · filed 2019-11-07 |
| 2019-08-02 | 34.01M shares 10-Q · filed 2019-08-06 |
| 2019-05-07 | 33.88M shares 10-Q · filed 2019-05-09 |
| 2019-03-06 | 33.88M shares 10-K · filed 2019-03-12 |
| 2018-11-06 | 33.80M shares 10-Q · filed 2018-11-08 |
| 2018-08-06 | 24.59M shares 10-Q · filed 2018-08-09 |
| 2018-05-09 | 24.56M shares 10-Q · filed 2018-05-10 |
| 2018-03-26 | 24.56M shares 10-K · filed 2018-04-02 |
| 2017-10-31 | 24.52M shares 10-Q · filed 2017-11-07 |
| 2017-07-31 | 24.23M shares 10-Q · filed 2017-08-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |